CLINICAL PHARMACOLOGY OF VECURONIUM IN CHILDREN
Open Access
- 1 September 1986
- journal article
- research article
- Published by Elsevier in British Journal of Anaesthesia
- Vol. 58 (9) , 996-1000
- https://doi.org/10.1093/bja/58.9.996
Abstract
Forty-seven children (ASA I or II) were studied during nitrous oxide-oxygen, halothane anaesthesia. The dose-response curve for vecuronium was determined after the injection of a single bolus (40, 55 or 70 μg kg-1) to 33 patients. The ED50 and ED95 were 31 and 64 μg kg−1 respectively. Fourteen children received a larger dose (100 μg kg−1); good intubating conditions were obtained in all of these within 2 min. After a single bolus (100 μg kg−1) the duration of action was 36.5 min and the recovery index was 9.3 min. In patients who received small maintenance doses (25 μg kg−1) after a single bolus (100 μg kg−1) the recovery index after the last maintenance dose was not increased. There were no significant changes in heart rate or arterial pressure. In children, has a vecuronium has a short duration of action and lacks cumulative or cardiovascular side affects.This publication has 6 references indexed in Scilit:
- CARDIAC EFFECTS OF VECURONIUM AND PANCURONIUM DURING HALOTHANE ANAESTHESIABritish Journal of Anaesthesia, 1983
- Neuromuscular Effects of Vecuronium (ORG NC45) in Infants and Children during N2O, Halothane AnesthesiaAnesthesiology, 1983
- REPETITIVE ADMINISTRATION OF PANCURONIUM AND VECURONIUM (Org NC 45, NORCURON) IN PATIENTS UNDERGOING LONG LASTING OPERATIONSBritish Journal of Anaesthesia, 1982
- Potency Determination for Vecuronium (ORG NC45)Anesthesiology, 1982
- Clinical Pharmacology of ORG NC45 (NorcuronTM)Anesthesiology, 1981
- The Neuromuscular Blocking Action of ORG NC 45, A New Pancuronium Derivative, in Anaesthetized PatientsBritish Journal of Anaesthesia, 1980